{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:36:33Z","timestamp":1784133393767,"version":"3.55.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"grunenthal Netherlands"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To investigate the coagulation system in gout patients and associations between disease activity and levels of coagulation markers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A prospective cohort study was performed with data from 30 Dutch gout patients. Levels of coagulation markers including APTT, PT, D-dimer, prothrombin F1\u2009+\u20092, von Willebrand factor, and thrombin generation parameters were analyzed at baseline and 1-year visit. These markers were related to clinical markers of gout disease activity including the Gout Activity Score (GAS). Our hypothesis was that patients with gout and active disease have increased levels of coagulation markers and that a decrease in disease activity would lead to normalization of coagulation activity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A higher GAS was associated with increased levels of thrombin generation parameters including ETP (<jats:italic>\u00df<\/jats:italic>\u2009=\u20090.48, <jats:italic>p<\/jats:italic>\u2009=\u20090.01), peak thrombin (<jats:italic>\u00df<\/jats:italic>\u2009=\u20090.60, <jats:italic>p<\/jats:italic>\u2009=\u20090.001), and velocity index (<jats:italic>\u00df<\/jats:italic>\u2009=\u20090.57, <jats:italic>p<\/jats:italic>\u2009=\u20090.002). Tophaceous gout and higher SUA levels were associated with thrombin generation parameters. After 1\u00a0year, thrombin generation parameters showed a small procoagulant trend despite a moderate decrease in disease activity. Prospectively measured changes in disease activity according to the GAS were not associated with any of the coagulation markers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Patients with active gout have higher levels of thrombin generation markers, indicating a link between disease activity and coagulation. A change in disease activity after 1\u00a0year was not associated with significant changes in coagulation markers, probably due to prolonged low-grade inflammation. Future studies should focus on levels of coagulation markers in comparison with the general population and the effect of adequate gout treatment.<jats:table-wrap><jats:table><jats:tbody>\n                      <jats:tr>\n                        <jats:td colspan=\"2\">Key Points<jats:italic>\u2022 Patients with gout have an increased risk of cardiovascular events.<\/jats:italic><jats:italic>\u2022 High disease activity was associated with higher levels of thrombin generation markers.<\/jats:italic><jats:italic>\u2022 Over time, small decreases in inflammation were associated with a decrease in D-dimer and thrombin generation.<\/jats:italic><\/jats:td>\n                      <\/jats:tr>\n                    <\/jats:tbody><\/jats:table><\/jats:table-wrap><\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10067-022-06047-9","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T03:04:33Z","timestamp":1643684673000},"page":"1809-1815","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Coagulation in gout: is there a link with disease activity?"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1715-9555","authenticated-orcid":false,"given":"Daisy","family":"Vedder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn","family":"Gerritsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost C. M.","family":"Meijers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Nurmohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,1]]},"reference":[{"issue":"11","key":"6047_CR1","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nrrheum.2015.91","volume":"11","author":"CF Kuo","year":"2015","unstructured":"Kuo CF, Grainge MJ, Zhang W, Doherty M (2015) Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol 11(11):649\u2013662","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"6047_CR2","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","volume":"16","author":"M Dehlin","year":"2020","unstructured":"Dehlin M, Jacobsson L, Roddy E (2020) Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol 16(7):380\u2013390","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"6047_CR3","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1136\/annrheumdis-2014-205252","volume":"74","author":"LE Clarson","year":"2015","unstructured":"Clarson LE, Hider SL, Belcher J, Heneghan C, Roddy E, Mallen CD (2015) Increased risk of vascular disease associated with gout: a retrospective, matched cohort study in the UK clinical practice research datalink. Ann Rheum Dis 74(4):642\u2013647","journal-title":"Ann Rheum Dis"},{"key":"6047_CR4","doi-asserted-by":"publisher","first-page":"26541","DOI":"10.1038\/srep26541","volume":"6","author":"CC Chiu","year":"2016","unstructured":"Chiu CC, Chen YT, Hsu CY et al (2016) Association between previous history of gout attack and risk of deep vein thrombosis - a nationwide population-based cohort study. Sci Rep 6:26541","journal-title":"Sci Rep"},{"issue":"51","key":"6047_CR5","doi-asserted-by":"publisher","first-page":"e2140","DOI":"10.1097\/MD.0000000000002140","volume":"94","author":"CC Huang","year":"2015","unstructured":"Huang CC, Huang PH, Chen JH et al (2015) An independent risk of gout on the development of deep vein thrombosis and pulmonary embolism: a nationwide, population-based cohort study. Medicine (Baltimore) 94(51):e2140","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"6047_CR6","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/S2665-9913(20)30221-6","volume":"3","author":"R Hansildaar","year":"2021","unstructured":"Hansildaar R, Vedder D, Baniaamam M, Tausche AK, Gerritsen M, Nurmohamed MT (2021) Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout. Lancet Rheumatol 3(1):e58\u2013e70","journal-title":"Lancet Rheumatol"},{"issue":"13","key":"6047_CR7","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1001\/2012.jama.11741","volume":"308","author":"ME Holmqvist","year":"2012","unstructured":"Holmqvist ME, Neovius M, Eriksson J et al (2012) Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization. JAMA 308(13):1350\u20131356","journal-title":"JAMA"},{"issue":"6","key":"6047_CR8","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1136\/annrheumdis-2013-204767","volume":"73","author":"IA van den Oever","year":"2014","unstructured":"van den Oever IA, Sattar N, Nurmohamed MT (2014) Thromboembolic and cardiovascular risk in rheumatoid arthritis: role of the haemostatic system. Ann Rheum Dis 73(6):954\u2013957","journal-title":"Ann Rheum Dis"},{"key":"6047_CR9","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.cca.2020.08.012","volume":"510","author":"S Chen","year":"2020","unstructured":"Chen S, Huang X, Huang Y et al (2020) Role of plasma fibrinogen in assessing disease activity of patients with gout. Clin Chim Acta 510:483\u2013487","journal-title":"Clin Chim Acta"},{"issue":"4","key":"6047_CR10","first-page":"435","volume":"48","author":"Y Wu","year":"2018","unstructured":"Wu Y, Chu C, Song P, Yang Y, Lin C, Xu Q (2018) Plasma D-dimer is a promising indicator for the treatment of acute gouty attack. Ann Clin Lab Sci 48(4):435\u2013439","journal-title":"Ann Clin Lab Sci"},{"issue":"10","key":"6047_CR11","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","volume":"74","author":"T Neogi","year":"2015","unstructured":"Neogi T, Jansen TL, Dalbeth N et al (2015) 2015 Gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 74(10):1789\u20131798","journal-title":"Ann Rheum Dis"},{"key":"6047_CR12","doi-asserted-by":"publisher","unstructured":"Gaffo AL, Dalbeth N, Saag KG, Singh JA, Rahn EJ, Mudano AS, Chen YH, Lin CT, Bourke S, Louthrenoo W, Vazquez-Mellado J, Hern\u00e1ndez-Llinas H, Neogi T, Vargas-Santos AB, da Rocha Castelar-Pinheiro G, Amorim RBC, Uhlig T, Hammer HB, Elisee M, Perez-Ruiz F, Cavagna L, McCarthy GM, Stamp LK, Gerritsen M, Fana V, Sivera F, Taylor W (2018) Brief report: Validation of a definition of flare in patients with established gout. Arthritis Rheumatol 70(3):462\u2013467. https:\/\/doi.org\/10.1002\/art.40381","DOI":"10.1002\/art.40381"},{"issue":"10","key":"6047_CR13","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1002\/acr.22844","volume":"68","author":"CA Scire","year":"2016","unstructured":"Scire CA, Carrara G, Viroli C et al (2016) Development and first validation of a Disease Activity Score for gout. Arthritis Care Res (Hoboken) 68(10):1530\u20131537","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"3","key":"6047_CR14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.bjhh.2017.03.009","volume":"39","author":"RCF Duarte","year":"2017","unstructured":"Duarte RCF, Ferreira CN, Rios DRA, Reis HJD, Carvalho MDG (2017) Thrombin generation assays for global evaluation of the hemostatic system: perspectives and limitations. Rev Bras Hematol Hemoter 39(3):259\u2013265","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"1","key":"6047_CR15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000071636","volume":"33","author":"HC Hemker","year":"2003","unstructured":"Hemker HC, Giesen P, Al Dieri R et al (2003) Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 33(1):4\u201315","journal-title":"Pathophysiol Haemost Thromb"},{"issue":"1","key":"6047_CR16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.transci.2007.12.005","volume":"38","author":"AS Wolberg","year":"2008","unstructured":"Wolberg AS, Campbell RA (2008) Thrombin generation, fibrin clot formation and hemostasis. Transfus Apher Sci 38(1):15\u201323","journal-title":"Transfus Apher Sci"}],"updated-by":[{"DOI":"10.1007\/s10067-022-06102-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000}}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06047-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06047-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06047-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T01:04:57Z","timestamp":1653008697000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06047-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["6047"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06047-9","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s10067-022-06102-5","asserted-by":"object"}]},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,1]]},"assertion":[{"value":"27 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2022","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10067-022-06102-5","URL":"https:\/\/doi.org\/10.1007\/s10067-022-06102-5","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study complies with the Declaration of Helsinki and was approved by the local ethics committee METC Slotervaart Amsterdam, the Netherlands. Informed consent has been obtained from all subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Patients were not involved in the design of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}